Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-5448|16|3|164-176

ISSN： 1399-543x

Source： PEDIATRIC DIABETES (ELECTRONIC), Vol.16, Iss.3, 2015-05, pp. : 164-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin degludec in Type 1 diabetes

By Eligar Vinay S   Bain Stephen C  

Clinical Investigation, Vol. 3, Iss. 10, 2013-10 ,pp. : 943-950

Future Science

Access to resources Recommend Favorite

Insulin degludec/insulin aspart produces a dose‐proportional glucose‐lowering effect in subjects with type 1 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 659-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes

By  

DIABETIC MEDICINE, Vol. 33, Iss. 10, 2016-10 ,pp. : 1360-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD‐ON)

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 636-644

John Wiley & Sons Inc

Access to resources Recommend Favorite

An economic assessment of analogue basal–bolus insulin versus human basal–bolus insulin in subjects with type 1 diabetes in the UK

By Palmer Andrew J.   Valentine William J.   Ray Joshua A.   Foos Volker   Lurati Francesco   Smith Inger   Lammert Morten   Roze Stéphane  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 895-901

Informa Healthcare

Access to resources Recommend Favorite